QuidelOrtho Corporation

NasdaqGS:QDEL Stock Report

Market Cap: US$3.0b

QuidelOrtho Future Growth

Future criteria checks 0/6

QuidelOrtho is forecast to grow earnings and revenue by 98.5% and 1% per annum respectively. EPS is expected to grow by 98.6% per annum. Return on equity is forecast to be 6.2% in 3 years.

Key information

98.5%

Earnings growth rate

98.6%

EPS growth rate

Medical Equipment earnings growth16.4%
Revenue growth rate1.0%
Future return on equity6.2%
Analyst coverage

Good

Last updated12 Dec 2024

Recent future growth updates

Recent updates

QuidelOrtho: Highly Levered With Questionable Growth

Nov 26

Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S

Nov 17
Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S

QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

Sep 15
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

Aug 09
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

QuidelOrtho: Attractive Valuation Despite Weak Performance

Apr 13

We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

Apr 08
We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

Feb 15
QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

Mar 13
QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Feb 18
QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

Nov 25
An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

Earnings and Revenue Growth Forecasts

NasdaqGS:QDEL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,881-24274667
12/31/20252,766-984234278
12/31/20242,773-1,896141358
9/29/20242,818-1,867-97100N/A
6/30/20242,835-1,859-17023N/A
3/31/20242,863-1,765-11991N/A
12/31/20232,998-1071280N/A
10/1/20233,12213147369N/A
7/2/20233,16245109318N/A
4/2/20233,110118389573N/A
1/1/20233,266549744885N/A
10/2/20223,0368109261,037N/A
7/3/20222,7621,0069361,124N/A
4/3/20222,3261,006484721N/A
1/2/20221,699704513806N/A
10/3/20211,871883634924N/A
7/4/20211,837900712917N/A
3/31/20211,8629481,0171,154N/A
1/3/20211,662810565630N/A
9/30/20201,005371194238N/A
6/30/2020655155152181N/A
3/31/202056288135163N/A
12/31/201953573107134N/A
9/30/201951575102130N/A
6/30/201950669117147N/A
3/31/201950165102133N/A
12/31/201852274105136N/A
9/30/20185053777104N/A
6/30/201843820N/A67N/A
3/31/201837312N/A34N/A
12/31/2017278-8N/A28N/A
9/30/2017216-5N/A33N/A
6/30/20172140N/A38N/A
3/31/20172154N/A49N/A
12/31/2016192-14N/A12N/A
9/30/2016189-12N/A11N/A
6/30/2016187-12N/A11N/A
3/31/2016183-14N/A-3N/A
12/31/2015194-6N/A37N/A
9/30/20152061N/A38N/A
6/30/2015201-4N/A42N/A
3/31/2015197-2N/A45N/A
12/31/2014184-7N/A36N/A
9/30/2014169-13N/A19N/A
6/30/2014160-12N/A14N/A
3/31/2014158-6N/A13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: QDEL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: QDEL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: QDEL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: QDEL's revenue (1% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: QDEL's revenue (1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: QDEL's Return on Equity is forecast to be low in 3 years time (6.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:04
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

QuidelOrtho Corporation is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Ishan MajumdarBaptista Research
Mark MassaroCanaccord Genuity